NASDAQ · ATHE
Alterity Therapeutics Limited
$2.18-$0.05 (-2.4%)
Alterity Therapeutics Limited’s quoted price sits in the lower half of its reported 52-week range, 62.99% below the high.
Loading market information…
AMEX · CCEL · USD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:29 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Cryo-Cell International, Inc.’s quoted price sits in the upper half of its reported 52-week range, 6.24% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Cryo-Cell International, Inc.’s forward annual dividend is $0.60 per share, paid quarterly. The forward yield is 11.74% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Cryo-Cell International, Inc.’s next earnings report is currently expected on Feb 26, 2027, with estimated earnings per share of $0.05. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Cryo-Cell International, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:56 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Jul 15, 2025 |
| $0.04+233.33% vs estimate |
| $7.93M-0.65% vs estimate |
| Q1 2025 | Apr 14, 2025 | $0.03+200.0% vs estimate | $7.97M+0.89% vs estimate |
|---|
| Q4 2024 | Feb 26, 2025 | $0.26+2,500.0% vs estimate | $8.02M+0.45% vs estimate |
|---|
THE ANALYST VIEW
1 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$2.18-$0.05 (-2.4%)
Alterity Therapeutics Limited’s quoted price sits in the lower half of its reported 52-week range, 62.99% below the high.
$2.04$0.00 (0.0%)
Mural Oncology plc’s quoted price sits in the lower half of its reported 52-week range, 56.96% below the high.
$7.08-$0.23 (-3.17%)
Rockwell Medical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 45.13% below the high.
$2.94-$0.04 (-1.34%)
111, Inc.’s quoted price sits in the lower half of its reported 52-week range, 73.68% below the high.
$2.93-$0.15 (-4.87%)
Evaxion Biotech A/S’s quoted price sits in the lower half of its reported 52-week range, 57.66% below the high.
$0.53-$0.01 (-0.96%)
Jasper Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 78.23% below the high.
$4.04-$0.16 (-3.81%)
P3 Health Partners Inc.’s quoted price sits in the lower half of its reported 52-week range, 76.08% below the high.
$0.94-$0.03 (-3.41%)
NeuroOne Medical Technologies Corporation’s quoted price sits in the lower half of its reported 52-week range, 84.69% below the high.
